• Cy3 TSA Fluorescence System Kit for Liver Cancer

  2026-10-02

  Discover how the Cy3 TSA Fluorescence System Kit can translate mechanistic findings on SIX1-driven lipid synthesis into spatially resolved assays. This guide combines TSA chemistry, liver cancer biology, controls, and practical assay-design decisions for detecting low-abundance biomolecules.

• ALC-0159: Reliable LNP Viability Assays

  2026-10-01

  This scenario-based guide shows how ALC-0159 (SKU B8596) can be incorporated into controlled mRNA lipid nanoparticle workflows without confusing a formulation excipient with an assay reporter. It connects assay controls, formulation comparisons, and evidence limits to practical selection of an ALC-0159 PEG lipid.

• Tomivosertib and the Translational Logic of eIF4E

  2026-10-01

  Tomivosertib offers translational researchers a precise way to interrogate MNK1/2-dependent eIF4E phosphorylation across oncology, metabolic, neuronal, and inflammatory models. This article connects the AMPK-MNK-eIF4E metabolic pathway to selective translation, tumor biology, and practical study design.

• SN-38 Disrupts FUBP1–FUSE Binding in Cancer Cells

  2026-09-30

  The reference study identified camptothecin and SN-38 as inhibitors of the FUBP1–FUSE DNA interaction, revealing a regulatory mechanism beyond their established topoisomerase I activity. Its findings support testing FUBP1-dependent transcription alongside DNA damage, apoptosis, and cell-cycle endpoints in carefully matched cancer models.

• Cy5 Goat Anti-Mouse IgG (H+L) for Vaccine Assays

  2026-09-30

  Explore how the Cy5 Goat Anti-Mouse IgG (H+L) Antibody can connect ferritin-based vaccine research with rigorous fluorescent endpoint design. This article translates particle-immunology findings into practical choices for mouse IgG detection, multiplexing, and assay validation.

• ABT-888 (Veliparib) DNA Repair Workflow

  2026-09-29

  ABT-888 (Veliparib) is a selective PARP1/2 inhibitor for building DNA damage-response, chemotherapy-sensitization, and radiation-response assays. This guide connects practical dosing and assay controls with colorectal cancer models and the biomarker-led CHK1 research landscape.

• IL-2 Human Recombinant: Mechanism and Workflow

  2026-09-29

  IL-2, human recombinant is a research cytokine for studying interleukin-2 receptor signaling in receptor-competent cells. The cited FUS–SMN study establishes a separate neuronal phase-separation mechanism and does not demonstrate that IL-2 modulates neuronal granules.

• γH2AX DNA Damage Detection Kit for DSB Research

  2026-09-28

  Translate radiation, nanoparticle, and genotoxicity experiments into measurable nuclear γ-H2AX signals with a red-fluorescence workflow suited to microscopy and high-content screening. This guide combines practical assay setup, treatment-specific controls, and troubleshooting for reproducible DNA double-strand break detection.

• Carvacrol in TRPA1 Redox-Sensing Workflows

  2026-09-28

  Use Carvacrol as a non-electrophilic TRPA1 agonist to test channel function after oxidative challenge—not as a substitute for a reactive oxygen species. This workflow separates acute ion-channel readouts from Carvacrol’s distinct cell-cycle and apoptosis research applications, with practical controls for each.

• Topotecan HCl Workflows for Cancer Assays

  2026-09-27

  Use Topotecan HCl to study replication-linked DNA damage while separating growth arrest from actual cell killing. Model-specific concentration and exposure windows, paired with distinct response readouts, make its cancer-assay results more interpretable.

• Amikacin Sulfate Workflows for NTM Research

  2026-09-26

  Pair extracellular CFU measurements with intracellular dendritic-cell assays to distinguish Amikacin activity from delivery and cell-response effects. This workflow also shows how kidney-safety context can inform interpretation without implying an unproven interaction between nicotine exposure and amikacin.

• Cy3 TSA Fluorescence System Kit: Cancer Research

  2026-09-25

  The Cy3 TSA Fluorescence System Kit uses HRP-catalyzed tyramide deposition to amplify fluorescence microscopy detection in IHC, ICC, and ISH. It can support detection of low-abundance biomolecules, but it does not replace target-specific probes, antibodies, or assay validation.

• TCF25 Links Glucose Sensing to Lysosomal Cell Death

  2026-09-25

  A genome-wide CRISPR-Cas9 screen identifies TCF25 as a regulator that helps cells adapt to glucose deprivation by enhancing V-ATPase-dependent lysosomal acidification. With prolonged starvation, the same pathway promotes ferritinophagy and lysosome-dependent cell death, while TCF25 deficiency protects mice in a hepatic ischemia-reperfusion model.

• E-4031 for 3D Cardiac Electrophysiology Research

  2026-09-24

  Pair E-4031-mediated hERG blockade with shell microelectrode arrays to test how delayed repolarization changes electrical wave propagation across cardiac organoids—not just activity at a planar contact surface. This workflow combines a controlled dose-response, spatial mapping, and calcium-imaging validation while flagging key limits in interpreting proarrhythmic phenotypes.

• Genotyping Kit for target alleles: PCR workflows

  2026-09-24

  See how single-tube DNA preparation can simplify PCR genotyping across insects, tissues, fish, and cells—without phenol/chloroform extraction or a separate DNA column. The workflow also clarifies where rapid allele genotyping can support mechanistic studies, and where expression assays are still required.

8527 records 1/569 page Next 12345 下5页 Last page